Skip to main content

Doyle William F's Form 4 filing

NovoCure Ltd (NVCR) · filed Mar 5, 2026

Accession no.
0001194459-26-000001
Filed
Mar 5, 2026
Trade date
Mar 3, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $933.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Doyle William FCIK 0001194459Director, Officer (Executive Chairman)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+200,000$0.00$0200,000Direct
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+200,284$0.00$0400,284Direct
Mar 3, 2026Ordinary SharesSSaleDisposed−50,557$12.79F4−$646,624.03349,727Direct
Mar 3, 2026Ordinary SharesSSaleDisposed−21,330$13.43F5−$286,461.9328,397Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+258,445$0.00$0258,445Direct
Mar 3, 2026Ordinary SharesAGrant or awardAcquired+30,072$0.00$0288,517Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

This transaction was executed in multiple trades at prices ranging from $12.299 USD to $13.277 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.52 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)